Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Esculetin, also known as a hydroxycoumarin, is a derivative of coumarin found in various plant species such as Cichorium intybus (chicory), Bougainvillea spectabilis, Artemisia capillaris, and leaves of Citrus limonia (Rutaceae), Ceratostigma willmottianum, among others. It is a yellowish crystalline powder that exhibits multiple pharmacological activities, making it a versatile compound with potential applications in various industries.

305-01-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 305-01-1 Structure
  • Basic information

    1. Product Name: Esculetin
    2. Synonyms: CICHORIGENIN;CICHERINGENIN;ESCULETOL;ESCULETIN;LABOTEST-BB LT00233229;AESCULETIN;AKOS 215-98;6,7-DIHYDROXY-CHROMEN-2-ONE
    3. CAS NO:305-01-1
    4. Molecular Formula: C9H6O4
    5. Molecular Weight: 178.14
    6. EINECS: 206-161-5
    7. Product Categories: Coumarins;Analytical Chemistry;Mass Spectrometry;Matrix Materials (MALDI-TOF-MS);chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;Inhibitors;Coumarin;Fluorescent
    8. Mol File: 305-01-1.mol
  • Chemical Properties

    1. Melting Point: 271-273 °C(lit.)
    2. Boiling Point: 270.35°C (rough estimate)
    3. Flash Point: 201.4 °C
    4. Appearance: Light yellow/powder
    5. Density: 1.3431 (rough estimate)
    6. Vapor Pressure: 0.000164mmHg at 25°C
    7. Refractive Index: 1.4500 (estimate)
    8. Storage Temp.: 2-8°C
    9. Solubility: Solubility Almost insoluble in boiling water, ether; soluble in
    10. PKA: 1.71(at 25℃)
    11. Water Solubility: slightly soluble
    12. Merck: 14,3697
    13. BRN: 152788
    14. CAS DataBase Reference: Esculetin(CAS DataBase Reference)
    15. NIST Chemistry Reference: Esculetin(305-01-1)
    16. EPA Substance Registry System: Esculetin(305-01-1)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36-37/39
    4. WGK Germany: 3
    5. RTECS: GN6382500
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 305-01-1(Hazardous Substances Data)

305-01-1 Usage

Uses

Used in Pharmaceutical Industry:
Esculetin is used as an antifungal, hepatoprotective, and IL-1 inhibitor agent, providing therapeutic benefits in treating various health conditions. Its ability to upregulate death receptor 4 (DR4) and 5 (DR5) protein expression, along with enhancing TRAIL-induced apoptosis, makes it a promising candidate for cancer treatment. Additionally, it inhibits the activity of 12-LO (12-lipoxygenase) and decreases leukotriene biosynthesis during 5-LO inhibition, further contributing to its potential as a pharmaceutical agent.
Used in Cosmetic Industry:
In the cosmetic industry, esculetin is used in filters for the absorption of ultraviolet light, providing protection against harmful UV rays and reducing the risk of skin damage and premature aging.
Used in Research Applications:
Esculetin's ability to modulate various signaling pathways and enzyme activities makes it a valuable tool in research for studying the mechanisms of various diseases and potential therapeutic interventions.

Purification Methods

It forms prisms from AcOH, aqueous EtOH or aqueous MeOH, and provides leaflets on sublimation in a vacuum. [Kagan J Am Chem Soc 88 2617 1966, Marby et al. Phytochemistry 4 492 1965.] Esculin (the 6-glucoside) has m 215o(dec), [] D -41o (c 5, pyridine). [Beilstein 18 III/IV 1322, 18/3 V 202.]

Check Digit Verification of cas no

The CAS Registry Mumber 305-01-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,0 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 305-01:
(5*3)+(4*0)+(3*5)+(2*0)+(1*1)=31
31 % 10 = 1
So 305-01-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H9ClO/c14-12-9-5-4-8-11(12)13(15)10-6-2-1-3-7-10/h1-9H

305-01-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (E0386)  Esculetin  >98.0%(HPLC)(T)

  • 305-01-1

  • 1g

  • 440.00CNY

  • Detail
  • Alfa Aesar

  • (A15393)  6,7-Dihydroxycoumarin, 98+%   

  • 305-01-1

  • 1g

  • 539.0CNY

  • Detail
  • Alfa Aesar

  • (A15393)  6,7-Dihydroxycoumarin, 98+%   

  • 305-01-1

  • 5g

  • 2182.0CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001611)  Esculetin  European Pharmacopoeia (EP) Reference Standard

  • 305-01-1

  • Y0001611

  • 1,880.19CNY

  • Detail

305-01-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name esculetin

1.2 Other means of identification

Product number -
Other names 6,7-dihydroxy-2H-chromen-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:305-01-1 SDS

305-01-1Synthetic route

6-hydroxy-7-phenylmethoxy-2H-1-benzopyran-2-one
895-61-4

6-hydroxy-7-phenylmethoxy-2H-1-benzopyran-2-one

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With hydrogen; palladium 10% on activated carbon In methanol Product distribution / selectivity;100%
malic acid
617-48-1

malic acid

1,2,4-triacetoxybenzene
613-03-6

1,2,4-triacetoxybenzene

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With sulfuric acid for 2h; Heating;85%
Stage #1: malic acid; 1,2,4-triacetoxybenzene With sulfuric acid at 100℃; for 2h;
Stage #2: With acetic acid at 120℃; for 18h;
78%
With sulfuric acid at 80℃; for 1.5h;65%
ayapin
494-56-4

ayapin

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
Stage #1: ayapin; aluminum tri-bromide In ethanethiol at 0 - 20℃;
Stage #2: With hydrogenchloride In water at 0 - 20℃; Product distribution / selectivity;
84.4%
esculetin acetonide

esculetin acetonide

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With water; acetic acid Product distribution / selectivity;83.7%
With hydrogenchloride; water at 120℃; for 2h; Product distribution / selectivity;72%
2,4,5-trihydroxybenzaldehyde
35094-87-2

2,4,5-trihydroxybenzaldehyde

acetic anhydride
108-24-7

acetic anhydride

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With sodium acetate In N,N-dimethyl-formamide at 180℃; for 5h; Product distribution / selectivity;80%
Scoparone
120-08-1

Scoparone

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With aluminium(III) iodide In acetonitrile at 80℃; for 18h;77%
cis-caffeic acid
331-39-5

cis-caffeic acid

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With phenolase 1.) sodium phosphate buffer pH=6.6, room temp., 40 min; 2.) boiling, 3 min;40 mg
esculin
531-75-9

esculin

A

D-Glucose
2280-44-6

D-Glucose

B

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With sulfuric acid
With citrate buffer; phosphate buffer; soybean β-glucosidase at 40℃; pH=5.0; Enzyme kinetics;
With β-cyclodextrin dicyanohydrin; Fe(III) ammonium citrate In phosphate buffer at 25 - 60℃; pH=8.0; Kinetics;
esculin
531-75-9

esculin

A

alpha-D-glucopyranose
492-62-6

alpha-D-glucopyranose

B

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With sulfuric acid hydrolysis;
4-(N,N-dimethylamino)phenol
619-60-3

4-(N,N-dimethylamino)phenol

C9H5O4

C9H5O4

A

aesculetin
305-01-1

aesculetin

B

4-(N,N-dimethylamino)phenoxyl radical
54737-34-7

4-(N,N-dimethylamino)phenoxyl radical

Conditions
ConditionsYield
With potassium hydroxide In water Equilibrium constant; Irradiation;
esculin
531-75-9

esculin

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With acetate buffer; β-glucosidase at 37℃;
With MES buffer; β-glucosidase at 37℃; for 0.5h; pH=7.0;
With naringinase from Aspergillus aculeatus JMUdb058 In aq. buffer at 50 - 100℃; for 0.583333h; pH=4; Kinetics; Enzymatic reaction;
With water; acetic acid In ethanol at 150℃; under 15201 Torr; for 1h; pH=2.6; Reagent/catalyst; Microwave irradiation; Sealed tube;
aesculin

aesculin

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With diluted acid
With emulsin
With hydrogenchloride Behandeln mit Wasser, in Alkohol und mit Bleiacetat; anschliessend Behandeln mit Alkohol, Wasser und Schwefelwasserstoff;
durch Spaltung mit Aesculase;
cichoriin

cichoriin

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With sulfuric acid
esculetin-carboxylic acid-(3)

esculetin-carboxylic acid-(3)

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
trockne Destillation;
acetic anhydride
108-24-7

acetic anhydride

oxyhydroquinonaldehyde

oxyhydroquinonaldehyde

aesculetin
305-01-1

aesculetin

Conditions
ConditionsYield
With sodium acetate at 170 - 180℃; Verseifen der erhaltenen Diacetylverbindung;
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

sodium peroxo disulfate

sodium peroxo disulfate

aqueous NaOH-solution

aqueous NaOH-solution

aesculetin
305-01-1

aesculetin

7-hydroxy-6-methoxy-2H-1-benzopyran-2-one
92-61-5

7-hydroxy-6-methoxy-2H-1-benzopyran-2-one

hydrogen iodide
10034-85-2

hydrogen iodide

A

aesculetin
305-01-1

aesculetin

B

methyl iodide
74-88-4

methyl iodide

hydrogenchloride
7647-01-0

hydrogenchloride

6,7-dihydroxy-2-oxo-chroman-3-sulfonic acid

6,7-dihydroxy-2-oxo-chroman-3-sulfonic acid

A

aesculetin
305-01-1

aesculetin

B

sulfur dioxide

sulfur dioxide

sulfuric acid
7664-93-9

sulfuric acid

6,7-dihydroxy-2-oxo-chroman-3-sulfonic acid

6,7-dihydroxy-2-oxo-chroman-3-sulfonic acid

A

aesculetin
305-01-1

aesculetin

B

sulfur dioxide

sulfur dioxide

esculin
531-75-9

esculin

A

aesculetin
305-01-1

aesculetin

B

sodium disulfite

sodium disulfite

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1) K2CO3, 2) 5percent H2SO4 / acetone
2: AlCl3
View Scheme

305-01-1Relevant articles and documents

Photo-degradation of trans-caffeic acid in aqueous solution and influence of complexation by metal ions

Le Person, Anna?g,Lacoste, Anne-Sophie,Cornard, Jean-Paul

, p. 10 - 19 (2013)

The photo-degradation of metal complexes of caffeic acid was compared to the photo-degradation of free caffeic acid by using UV-vis spectroscopy and HPLC-ESI-mass spectrometry. This article reports first the determination of the products that are formed from the photo-degradation of trans-caffeic acid in aqueous solution and the investigation of the mechanism by a kinetic approach. The good fit between the model and the experimental concentration profiles confirms the photo-isomerization route of the molecule to cis-caffeic acid which then undergoes a cyclization to form the esculetin photo-product. In addition, it reveals, for the first time, another route of major importance leading to the product vinylcatechol. The presence of oxygen leads to an increase of the photo-isomerization rate. Then we report that metallic cations such as Al(III), Pb(II) and Cu(II) can influence the rate and mechanism of caffeic acid photodegradation. Al(III) ions slow down the photo-degradation whereas Pb(II) and Cu(II) ions have a promoter effect on the production of esculetin. In all cases, the photo-isomerization is reduced by the presence of metal ions and the formation of vinylcatechol does not occur.

Colorimetric and fluorescence signalling of thioesculetin in presence of oxidising agent

Shinde, Rupali G.,Khan, Ayesha A.,Barik, Atanu

, (2018)

Abstract: Thioesculetin (TE) is a sulfur analogue of esculetin. The UV-Vis absorption maximum of TE at 470 nm shifted to 357 nm in the presence of oxidising agent such as m-chloroperoxy benzoic acid (m-CPBA). With gradual increase in the m-CPBA concentrat

Synthesis and evaluation of substituted 8,8-dimethyl-8H-pyrano[2,3-f]chromen-2-one derivatives as vasorelaxing agents

Singh, Sarita,Agarwal, Karishma,Iqbal, Hina,Yadav, Pankaj,Yadav, Deepika,Chanda, Debabrata,Tandon, Sudeep,Khan, Feroz,Gupta, Anil Kumar,Gupta, Atul

, (2020)

A series of substituted 8,8-dimethyl-8H-pyrano[2,3-f]chromen-2-ones (chromeno-coumarin hybrids) was synthesized from scopoletin (11) as vasorelaxing agents. The synthesized compounds 21a-f, 22, 23a-e and scopoletin (11) were evaluated for vasorelaxation in endothelium intact rat main mesenteric artery (MMA). Compounds 11, 21a, 21c-f and 22 showed significant vasorelaxation in precontracted MMA within the range of EC50 value 1.58–5.02 μM. These derivatives presented 29.40–70.89 fold increased sensitivity for experimental tissue compared to scopoletin (11), the parent molecule. Among others, 22 was found to be the most active compound which had EC50 1.58 μM with 70.89 fold increased sensitivity. The mechanistic evaluation of 22 showed that it exerted vasorelaxation through Ca2+-activated K+ (BKca) channel and the effect was endothelium-independent.

Study of umbelliferone hydroxylation to esculetin catalyzed by polyphenol oxidase

Garcia-Molina, Sea,Munoz-Munoz, Joseph Louis,Garcia-Molina, Francis,Rodriguez-Lopez, Joseph Neptune,Garcia-Canovas, Francis

, p. 1140 - 1145 (2013)

We characterize umbelliferone, a derivative of 2,4-dihydroxycoumaric acid, as a substrate of polyphenol oxidase. This enzyme hydroxylates umbelliferone to esculetin, its o-diphenol, and then oxidizes it to o-quinone. The findings show that umbelliferone, an intermediate in one of the coumarin biosynthesis pathways, may be transformed into its o-diphenol, esculetin, which is also an intermediate in the same pathway. The activity of the enzyme on umbelliferone was followed by measuring the consumption of oxygen, spectrophotometrically and by HPLC. Kinetic constants characterizing the hydroxylation process were: k cat=0.09±0.02 s-1 and Km=0.17±0. 06 mm. The o-diphenol, esculetin, was a better substrate and when its oxidation was followed spectrophotometrically, the kinetic constants were: k cat=1.31±0.25 s-1 and Km=0.035±0. 002 mM. Both compounds therefore can be considered as alternative substrates to l-tyrosine and l-3,4-dihydroxyphenylalanine (l-DOPA), since both indirectly inhibit melanogenesis.

Structure-Activity Relationship Study of Hydroxycoumarins and Mushroom Tyrosinase

Asthana, Shailendra,Zucca, Paolo,Vargiu, Attilio V.,Sanjust, Enrico,Ruggerone, Paolo,Rescigno, Antonio

, p. 7236 - 7244 (2015)

The structure-activity relationships of four hydroxycoumarins, two with the hydroxyl group on the aromatic ring of the molecule and two with the hydroxyl group replacing hydrogen of the pyrone ring, and their interactions with mushroom tyrosinase were studied. These compounds displayed different behaviors upon action of the enzyme. The two compounds, ar-hydroxylated 6-hydroxycoumarin and 7-hydroxycoumarin, were both weak substrates of the enzyme. Interestingly, in both cases, the product of the catalysis was the 6,7-hydroxycoumarin, although 5,6- and 7,8-isomers could also theoretically be formed. Additionally, both were able to reduce the formation of dopachrome when tyrosinase acted on its typical substrate, l-tyrosine. Although none of the compounds that contained a hydroxyl group on the pyrone ring were substrates of tyrosinase, the 3-hydroxycoumarin was a potent inhibitor of the enzyme, and the 4-hydroxycoumarin was not an inhibitor. These results were compared with those obtained by in silico molecular docking predictions to obtain potentially useful information for the synthesis of new coumarin-based inhibitors that resemble the structure of the 3-hydroxycoumarin.

Study of the Oxidative Cleavage Proposed in the Biogenesis of Transtaganolides/Basiliolides: Pyran-2-one Aromaticity-Mediated Regioselective Control and Biogenetic Implications

álvarez, José María,Jorge, Zacarías D.,Massanet, Guillermo M.

supporting information, (2020/03/05)

The synthetic feasibility of the oxidative cleavage: epoxidation of 7-O-geranylscopoletin followed by electrocyclic ring-opening, proposed in the biogenesis of transtaganolides/basiliolides is studied. Unlike the proposed pericyclic reactions, this pathway has not yet been addressed. Three synthetic strategies have been tested consisting of: i) Baeyer–Villiger oxidation of p-quinoids, ii) hydrolysis of quinone monoketals, or iii) direct fragmentation by using oxygen donors. Oxidation of the benzene ring of hydroxylated coumarins has been achieved using peroxyacids, but cleavage took place between undesired positions. The aromaticity conservation of the pyran-2-one cycle during oxidation is the controlling factor of these observed regioselectivities. The use of a 4,5-dihydroxy-2-methoxycinnamate model, in which the pyran-2-one ring does not exert influence on oxidation, has allowed the design of a synthetic sequence toward an analogue of the natural pyran-2-one isolated from Thapsia transtagana, key in the biogenesis. Mechanistic proposals for the obtained results as well as their biogenetic implications are raised.

Anchimerically Assisted Selective Cleavage of Acid-Labile Aryl Alkyl Ethers by Aluminum Triiodide and N, N-Dimethylformamide Dimethyl Acetal

Sang, Dayong,Yue, Huaxin,Zhao, Zhengdong,Yang, Pengtao,Tian, Juan

, p. 6429 - 6440 (2020/07/14)

Aluminum triiodide is harnessed by N,N-dimethylformamide dimethyl acetal (DMF-DMA) for the selective cleavage of ethers via neighboring group participation. Various acid-labile functional groups, including carboxylate, allyl, tert-butyldimethylsilyl (TBS), and tert-butoxycarbonyl (Boc), suffer the conditions intact. The method offers an efficient approach to cleaving catechol monoalkyl ethers and to uncovering phenols from acetal-type protecting groups such as methoxymethyl (MOM), methoxyethoxymethyl (MEM), and tetrahydropyranyl (THP) chemoselectively.

Regioselective IBX-Mediated Synthesis of Coumarin Derivatives with Antioxidant and Anti-influenza Activities

Bizzarri, Bruno M.,Botta, Lorenzo,Capecchi, Eliana,Celestino, Ignacio,Checconi, Paola,Palamara, Anna T.,Nencioni, Lucia,Saladino, Raffaele

, p. 3247 - 3254 (2018/01/02)

Different catechol and pyrogallol derivatives have been synthesized by oxidation of coumarins with 2-iodoxybenzoic acid (IBX) in DMSO at 25 °C. A high regioselectivity was observed in accordance with the stability order of the incipient carbocation or radical benzylic-like intermediate. The oxidation was also effective in water under heterogeneous conditions by using IBX supported on polystyrene. The new derivatives showed improved antioxidant effects in the DPPH test and inhibitory activity against the influenza A/PR8/H1N1 virus. These data represent a new entry for highly oxidized coumarins showing an antiviral activity possibly based on the control of the intracellular redox value.

Gastroprotective activity of synthetic coumarins: Role of endogenous prostaglandins, nitric oxide, non-protein sulfhydryls and vanilloid receptors

Sepulveda, Beatriz,Quispe, Cristina,Simirgiotis, Mario,Torres-Benítez, Alfredo,Reyes-Ortíz, Johanna,Areche, Carlos,García-Beltrán, Olimpo

, p. 5732 - 5735 (2016/11/25)

Natural or synthetic coumarins showed gastroprotective and antiulcer activity in animal models. In this study, we have synthetized twenty coumarins using classic methods to evaluate their gastroprotective effects on the ethanol/HCl-induced gastric lesion model in mice at 20?mg/kg. Among the coumarins synthetized, compounds 6 and 10 showed the greatest gastroprotective activity being as active as lansoprazole at 20?mg/kg and reducing gastric lesions by 75 and 76%, respectively. Then, in a second experiment, compounds 6 and 10 were re-evaluated in order to understand the possible mode of gastroprotective activity. Regarding coumarin 6, the protective effect was reduced by pre-treatment of the mice with N-ethylmaleimide and l-NAME suggesting that sulfhydryl compounds and endogenous nitric oxide are involved in its gastroprotective activity. While for coumarin 10 the effect was reduced by pre-treatment with indomethacin suggesting that prostaglandins are positively involved in its gastroprotective activity.

METHOD OF PRODUCING COMPOUND HAVING DECREASED SUGAR FROM GLYCOSIDE, EXTRACT, AND PHARMACEUTICAL AND FOOD COMPOSITIONS INCLUDING THE COMPOUND

-

Paragraph 52-55, (2015/01/07)

Provided are a method of producing a compound in which a sugar of a glycoside is reduced or removed, and an extract, a pharmaceutical composition, and a food composition including the compound.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 305-01-1